Last Funding Type: Series B
Total Funding: 295000000.0
Last Funding Date: 2021-10-27
Funding Status: Early Stage Venture
Employee Number: 101-250
Technology: Artificial Intelligence, Biotechnology, Machine Learning, Therapeutics
Investors Number: 13.0
Founded Date: 2018-12-01
Headquarters: New York, New York, United States
Industry: Medical BioTech
Investor Type: info@immunai.com
Acquisitions Number: 2